SE9803155D0 - A new composition - Google Patents

A new composition

Info

Publication number
SE9803155D0
SE9803155D0 SE9803155A SE9803155A SE9803155D0 SE 9803155 D0 SE9803155 D0 SE 9803155D0 SE 9803155 A SE9803155 A SE 9803155A SE 9803155 A SE9803155 A SE 9803155A SE 9803155 D0 SE9803155 D0 SE 9803155D0
Authority
SE
Sweden
Prior art keywords
composition
component
disorders
new composition
dicyclobutylamino
Prior art date
Application number
SE9803155A
Other languages
English (en)
Inventor
John Evenden
Seth-Olov Thorberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9803155A priority Critical patent/SE9803155D0/sv
Publication of SE9803155D0 publication Critical patent/SE9803155D0/sv
Priority to PCT/SE1999/001596 priority patent/WO2000015217A1/en
Priority to CA002342223A priority patent/CA2342223A1/en
Priority to AU63779/99A priority patent/AU6377999A/en
Priority to EP99951318A priority patent/EP1113792A1/en
Priority to JP2000569801A priority patent/JP2002524507A/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9803155A 1998-09-16 1998-09-16 A new composition SE9803155D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE9803155A SE9803155D0 (sv) 1998-09-16 1998-09-16 A new composition
PCT/SE1999/001596 WO2000015217A1 (en) 1998-09-16 1999-09-13 A new composition
CA002342223A CA2342223A1 (en) 1998-09-16 1999-09-13 A new composition
AU63779/99A AU6377999A (en) 1998-09-16 1999-09-13 A new composition
EP99951318A EP1113792A1 (en) 1998-09-16 1999-09-13 A new composition
JP2000569801A JP2002524507A (ja) 1998-09-16 1999-09-13 新規組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803155A SE9803155D0 (sv) 1998-09-16 1998-09-16 A new composition

Publications (1)

Publication Number Publication Date
SE9803155D0 true SE9803155D0 (sv) 1998-09-16

Family

ID=20412626

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9803155A SE9803155D0 (sv) 1998-09-16 1998-09-16 A new composition

Country Status (6)

Country Link
EP (1) EP1113792A1 (sv)
JP (1) JP2002524507A (sv)
AU (1) AU6377999A (sv)
CA (1) CA2342223A1 (sv)
SE (1) SE9803155D0 (sv)
WO (1) WO2000015217A1 (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1358177T3 (da) 2000-10-13 2006-12-04 Neurosearch As Behandling af affektbetonede lidelser ved den kombinerede virkning af en nikotinreceptoragonist og et monoaminergt stof
US8309107B2 (en) 2008-10-06 2012-11-13 Banner Pharmacaps, Inc. Stable solutions of orlistat for pharmaceutical dosage forms

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination

Also Published As

Publication number Publication date
WO2000015217A1 (en) 2000-03-23
AU6377999A (en) 2000-04-03
EP1113792A1 (en) 2001-07-11
CA2342223A1 (en) 2000-03-23
JP2002524507A (ja) 2002-08-06

Similar Documents

Publication Publication Date Title
SE9501567D0 (sv) A new combination
PT1237553E (pt) Combinacao de um inibidor de recaptacao da serotonina e de um antagonista, de um agonista inverso ou de um agonista parcial para o 5-ht2c
HUP9701068A2 (hu) Mirtazapint és egy vagy több szelektív szerotoninújrafelvétel-inhibitort tartalmazó gyógyászati készítmény
NO20060402L (no) 3-amino choman og 2-aminotetralinderivater
DE60044152D1 (de) Bupropion Metaboliten zur Behandlung von Angstzuständen
EA200001244A1 (ru) Комбинационная терапия для лечения биполярных расстройств
DE602004015257D1 (de) Verwendung von dem (1s,2r)-milnacipran-enantiomer zur herstellung eines arzneimittels
SE9800836D0 (sv) New Compounds
EA199900669A1 (ru) Промежуточные соединения для получения замещенных n-[аминоиминометил или аминометил)фенил]пропиламидов
DE60200492D1 (de) Kombination eines Inhibitoren der Serotoninwiederaufnahme und eines atypischen Antipsychotikums zur Behandlung von Depression, Zwangsneurosen und Psychosen
BR0109211A (pt) Compostos com atividade 5-ht1a úteis para o tratamento de distúrbios da retina externa
DK1436257T3 (da) Oxim-analogica af 1-alpha, 25-dihydroxy-vitamin-D3 med ringe kalcemisk virkning
EA200001218A1 (ru) Комбинационная терапия для лечения резистентной депрессии
MY152919A (en) Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
AR015448A1 (es) COMBINACIoN DE UN INHIBIDOR DE REABSORCIoN DE 5-HT CON UN ANTAGONISTA O AGONISTA PARCIAL DE H5-HT1B, PROCESO PARA SU PREPARACIoN, FORMULACIoN FARMACÉUTICA QUE LA CONTIENE, SU USO PARA PREPARAR MEDICAMENTOS PARA TRATAR TRASTORNOS AFECTIVOS Y KIT QUE CONTIENE DICHA COMBINACIoN
DE602004031893D1 (de) Verwendung des Enantiomers (1S, 2R) von Milnacipran zur Herstellung eines Arzneimittels
EP1254668A3 (en) Combination of a serotonin reuptake inhibitor and a GABA-A alpha 2/3 agonist for use in anxiety and depression
AR054435A1 (es) Agente para profilaxis o terapia contra la depresion o desorden de ansiedad
SE9804126D0 (sv) New pharmaceutical composition
HUP0303270A2 (hu) Antidepresszáns hatású izoxazolinszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
SE9803155D0 (sv) A new composition
BRPI0411175A (pt) combinação do modafinil analéptico e um antidepressivo para o tratamento da depressão
BR0309009A (pt) Método para o tratamento de hipersecreção de muco
SE9803157D0 (sv) A new composition
EA200501802A1 (ru) Сочетание аналептина модафинила и антидепрессанта для лечения депресии